Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Novel Non-Invasive Liver Fibrosis Tests Are Effective Biopsy Alternatives
February 2026
Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.
Read more
17 Dec 2021
The Cycle of Neurodegeneration in the Liver Associated with Fatty Liver Disease
Evidence has further shown a direct correlation between the severity of liver pathology and the level of nerve degeneration…
12 Nov 2021
An Incoming Epidemic
Dr. Fasiha Kanwal explores her work towards fighting non-alcoholic steatohepatitis (NASH), underlining the importance of changing lifestyles.
21 Sep 2021
New Discovery in Biliary Atresia Could Lead to Better Treatment
BILIARY atresia is a rare congenital condition resulting in inflamed and blocked bile ducts. This blockage prevents bile from being…
21 Sep 2021
Novel Algorithm Predicts Mortality Risk in Acute-on-Chronic Liver Failure
PATIENTS with acute-on-chronic liver failure (ACLF) typically only have 3 months to live and desperately require a liver transplant for…
12
Mins
21 Sep 2021
Using Innovation to Develop Digital Tools for Public Health During the COVID-19 Pandemic
This paper describes a case study of the co-design and development of two new COVID-19 digital services to support the Scottish…
8
Mins
21 Sep 2021
Liver Transplantation in Patients with Acute-on-Chronic Liver Failure: Challenging the Limits
The natural history of patients with cirrhosis is characterised by the development of acute decompensating events…
12
Mins
21 Sep 2021
Hepatic Manifestations of Lysosomal Storage Disorders: Differential Diagnosis, Investigations, and Treatment, Current and Upcoming
Hepatomegaly can be a presenting or associated feature of an inherited lysosomal storage disorder. Thus, a high index of suspicion should be maintained in patients without an aetiologic diagnosis. Read more.
14
Mins
21 Sep 2021
Portal Hypertension in Non-alcoholic Fatty Liver Disease in the Era of Non-invasive Assessment
Non-alcoholic fatty liver disease (NAFLD) is considered as one of the fastest emerging global health priorities due to the continuous…
Loading posts...
« Previous
1
…
42
43
44
45
46
…
76
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View